BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1691126)

  • 1. Bleomycin, vincristine, and mitomycin C (BOM) as second-line treatment after failure of cis-platinum-based combination chemotherapy for recurrent cervical cancer.
    Wheelock JB; Krebs HB; Goplerud DR
    Gynecol Oncol; 1990 Apr; 37(1):21-3. PubMed ID: 1691126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy for patients with advanced carcinoma of the cervix: trial of mitomycin-C, vincristine, bleomycin, and cisplatin.
    Giannone L; Brenner DE; Jones HW; Greco FA; Burnett LS
    Gynecol Oncol; 1987 Feb; 26(2):178-82. PubMed ID: 2433196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy for advanced and/or recurrent cervical cancer.
    Lahousen M; Pickel H; Tamussino K
    Arch Gynecol; 1987; 240(4):247-52. PubMed ID: 2440389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma.
    Shimizu Y; Akiyama F; Umezawa S; Ishiya T; Utsugi K; Hasumi K
    J Clin Oncol; 1998 May; 16(5):1869-78. PubMed ID: 9586903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleomycin, vincristine, mitomycin C, and cis-platinum in gynecologic squamous cell carcinomas: a high incidence of pulmonary toxicity.
    Chambers SK; Flynn SD; Del Prete SA; Chambers JT; Schwartz PE
    Gynecol Oncol; 1989 Mar; 32(3):303-9. PubMed ID: 2465939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced cervical cancer by a combination of peplomycin, vincristine, mitomycin-C, and cisplatin.
    Sugimori H; Iwasaka T; Fukuda K; Hayashi Y; Hachisuga T
    Gynecol Oncol; 1989 Aug; 34(2):180-2. PubMed ID: 2473949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II evaluation of cisplatin, bleomycin, and mitomycin-C in patients with recurrent squamous cell carcinoma of the cervix.
    Hoffman MS; Kavanagh JJ; Roberts WS; LaPolla JP; Fiorica JV; Hewitt S; Cavanagh D
    Gynecol Oncol; 1991 Feb; 40(2):144-6. PubMed ID: 1707024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of recurrent cervical cancer with cis-platinum and mitomycin C: a phase II study.
    Malviya VK; Deppe G; Schoenmaker M
    Am J Clin Oncol; 1989 Oct; 12(5):438-41. PubMed ID: 2508464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of advanced or recurrent squamous cell carcinoma of the uterine cervix with mitomycin-C, bleomycin, and cisplatin chemotherapy.
    Smith HO; Stringer CA; Kavanagh JJ; Gershenson DM; Edwards CL; Wharton JT
    Gynecol Oncol; 1993 Jan; 48(1):11-5. PubMed ID: 7678571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleomycin, vincristine, mitomycin-C, and cisplatin in the management of gynecological squamous cell carcinomas.
    Belinson JL; Stewart JA; Richards AL; McClure M
    Gynecol Oncol; 1985 Mar; 20(3):387-93. PubMed ID: 2579010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of advanced or recurrent cervical cancer by a new BOMP regimen consisting of bleomycin, vincristine, mitomycin-C, and low-dose consecutive cisplatin].
    Shimizu Y; Nakayama K; Seimiya Y; Yamakawa Y; Koi S; Yokosuka K; Teshima H; Chen JT; Fujimoto I; Yamauchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):549-56. PubMed ID: 1711555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of advanced cervical carcinoma].
    Asins E; Aznar I; Bernabeu JR; Lonjedo L; Ruiz F; ViƱas T; Gresa M; Llixiona J; Galbis M
    Rev Esp Oncol; 1985; 32(4):715-8. PubMed ID: 2465560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical effect of combination chemotherapy with peplomycin and mitomycin C (PM therapy) in recurrent uterine cervical cancer].
    Yokoyama T; Hiura M; Kaneko H; Yorishima M; Tanaka M; Chiba T
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):73-8. PubMed ID: 2447837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma.
    Weiner SA; Aristizabal S; Alberts DS; Surwit EA; Deatherage-Deuser K
    Gynecol Oncol; 1988 May; 30(1):1-6. PubMed ID: 2452769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for advanced cervical cancer with bleomycin, vincristine, mitomycin C, and cis-diamminedichloroplatinum(II) (BOMP).
    Vogl SE; Moukhtar M; Calanog A; Greenwald EH; Kaplan BH
    Cancer Treat Rep; 1980; 64(8-9):1005-7. PubMed ID: 6160911
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix.
    Tabata T; Takeshima N; Nishida H; Hirai Y; Hasumi K
    Anticancer Res; 2003; 23(3C):2885-90. PubMed ID: 12926129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intraarterial combination chemotherapy consisting of bleomycin, vincristine, mitomycin-C, and cisplatin (BOMP) for cervical cancer recurrence in the pelvis].
    Shimizu Y; Fujimoto I; Hasumi K; Masubuchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Nov; 43(11):1587-90. PubMed ID: 1719107
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adjuvant chemotherapy in radical surgery of cervix cancer].
    Lahousen M; Haas H; Pickel H
    Gynakol Rundsch; 1989; 29 Suppl 2():372-4. PubMed ID: 2482234
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination chemotherapy in the treatment of advanced squamous cell carcinoma of the uterine cervix.
    Chander S; Ghosh D; Aggarwal N
    Indian J Cancer; 1986 Mar; 23(1):43-8. PubMed ID: 2434412
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocol.
    Chambers SK; Lamb L; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1994 May; 53(2):161-9. PubMed ID: 7514557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.